313 related articles for article (PubMed ID: 10438495)
1. Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
Cherny RA; Legg JT; McLean CA; Fairlie DP; Huang X; Atwood CS; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Biol Chem; 1999 Aug; 274(33):23223-8. PubMed ID: 10438495
[TBL] [Abstract][Full Text] [Related]
2. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
3. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.
Cherny RA; Atwood CS; Xilinas ME; Gray DN; Jones WD; McLean CA; Barnham KJ; Volitakis I; Fraser FW; Kim Y; Huang X; Goldstein LE; Moir RD; Lim JT; Beyreuther K; Zheng H; Tanzi RE; Masters CL; Bush AI
Neuron; 2001 Jun; 30(3):665-76. PubMed ID: 11430801
[TBL] [Abstract][Full Text] [Related]
5. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.
Caragounis A; Du T; Filiz G; Laughton KM; Volitakis I; Sharples RA; Cherny RA; Masters CL; Drew SC; Hill AF; Li QX; Crouch PJ; Barnham KJ; White AR
Biochem J; 2007 Nov; 407(3):435-50. PubMed ID: 17680773
[TBL] [Abstract][Full Text] [Related]
7. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
Conte-Daban A; Day A; Faller P; Hureau C
Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
[TBL] [Abstract][Full Text] [Related]
8. Cu and Zn interactions with Aβ peptides: consequence of coordination on aggregation and formation of neurotoxic soluble Aβ oligomers.
Rana M; Sharma AK
Metallomics; 2019 Jan; 11(1):64-84. PubMed ID: 30234208
[TBL] [Abstract][Full Text] [Related]
9. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
[TBL] [Abstract][Full Text] [Related]
10. Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.
Huang X; Atwood CS; Moir RD; Hartshorn MA; Tanzi RE; Bush AI
J Biol Inorg Chem; 2004 Dec; 9(8):954-60. PubMed ID: 15578276
[TBL] [Abstract][Full Text] [Related]
11. Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer's Disease.
Kim N; Lee HJ
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299316
[TBL] [Abstract][Full Text] [Related]
12. Chelation and intercalation: complementary properties in a compound for the treatment of Alzheimer's disease.
Cherny RA; Barnham KJ; Lynch T; Volitakis I; Li QX; McLean CA; Multhaup G; Beyreuther K; Tanzi RE; Masters CL; Bush AI
J Struct Biol; 2000 Jun; 130(2-3):209-16. PubMed ID: 10940226
[TBL] [Abstract][Full Text] [Related]
13. Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.
Faller P; Hureau C; Berthoumieu O
Inorg Chem; 2013 Nov; 52(21):12193-206. PubMed ID: 23607830
[TBL] [Abstract][Full Text] [Related]
14. Metal complexing agents as therapies for Alzheimer's disease.
Bush AI
Neurobiol Aging; 2002; 23(6):1031-8. PubMed ID: 12470799
[TBL] [Abstract][Full Text] [Related]
15. The Rapid Exchange of Zinc(2+) Enables Trace Levels to Profoundly Influence Amyloid-β Misfolding and Dominates Assembly Outcomes in Cu(2+)/Zn(2+) Mixtures.
Matheou CJ; Younan ND; Viles JH
J Mol Biol; 2016 Jul; 428(14):2832-46. PubMed ID: 27320389
[TBL] [Abstract][Full Text] [Related]
16. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
17. Zinc takes the center stage: its paradoxical role in Alzheimer's disease.
Cuajungco MP; Fagét KY
Brain Res Brain Res Rev; 2003 Jan; 41(1):44-56. PubMed ID: 12505647
[TBL] [Abstract][Full Text] [Related]
18. A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease.
Savelieff MG; Liu Y; Senthamarai RR; Korshavn KJ; Lee HJ; Ramamoorthy A; Lim MH
Chem Commun (Camb); 2014 May; 50(40):5301-3. PubMed ID: 24326305
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
[TBL] [Abstract][Full Text] [Related]
20. Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.
Atrián-Blasco E; Conte-Daban A; Hureau C
Dalton Trans; 2017 Oct; 46(38):12750-12759. PubMed ID: 28937157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
